Partnerships

Milagen has had many research and commercial partners over the years to advance our product line and introduce them to the market. Scroll down to learn more.

We are currently looking for like-minded investors and commercial partners to co-develop and commercialize our cancer tests. Please contact us below to start the discussion.

Select Partnerships

Milagen entered into partnerships with researchers from leading academic institutions and medical centers in order to advance the development of immunodiagnostic assays for early detection, prognosis and therapy management. These collaborations provided invaluable clinical expertise, unbiased feedback, and the chance for third-party validation of its products.

Laboratorios Columbia S.A. de C.V. & Major Mexican Hospitals

September 28, 2023

Milagen and Laboratorios Columbia S.A. de C.V., agreed to conduct a major clinical study involving major Hospitals in Mexico City such as Instituto Mexicano de Seguro Social (IMSS), Instituto Nacional de Cancerologia (INCAN), Hospitals ABC and Hospitals la Candesa.

Laboratorios Columbia S.A. de C.V.

March 23, 2023

Milagen enter into partnership with Laboratorios Columbia S.A. de C.V., a pharmaceutical company in Mexico with 60 years of manufacturing and selling pharmaceutical products, for the commercialization of Milagen cancer care products in Mexico.

Uppsala University

March 30, 2018

Milagen enters into collaboration with Uppsala University in Sweden to study colorectal cancer biomarkers in cancer survivors followed over time.

The Instituto Nacional de Cancerología & Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

May 4, 2015

Milagen enters in a collaboration with the The Instituto Nacional de Cancerología and the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCAN, INCMNSZ) in Mexico to conduct a major clinical study regarding biomarkers related to cancer care.

ServaCare

June 10, 2013

Milagen establishes a strategic partnership with Servacare, a Mexico-based clinical laboratory, for the commercialization of cervical disease related products.

Laboratorios Grupo Columbia

April 18, 2011

Milagen enters into a partnership with Grupo Columbia for the commercialization of its IVD products in Mexico.

MD Anderson Cancer Center, Houston, TX

May 24, 2004

Milagen initiates research collaboration with MD Anderson Cancer Center, Houston, TX.

University of California Los Angeles (UCLA)

April 15, 2004

Publication of abstract in partnerships with UCLA.

University of California Los Angeles (UCLA)

November 24, 2003

Establishment of a research collaboration with University of California Los Angeles (UCLA) on third party validation of Milagen’s biomarkers.

National Cancer Institute (NCI)

November 21, 2003

Expansion of research collaboration with NCI.

Harvard School of Public Health

August 12, 2003

Milagen to initiate research collaboration with the Harvard School of Public Health.

H. Lee Moffitt Cancer Center & University of South Florida

June 12, 2003

Establishment of research collaboration with the H. Lee Moffitt Cancer Center and the University of South Florida.